All Stories

  1. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  2. Age at menarche and the risk of operative delivery
  3. The acute-phase protein SAA3 is present in the preterm human colostrum and breast milk
  4. Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development
  5. Endoplasmic reticulum stress regulates placental growth factor expression in human choriocarcioma cells
  6. 3D surface reconstruction of human terminal villi and the fetal capillary bed
  7. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early‐ and late‐onset pre‐eclampsia
  8. Influence of speed of sample processing on placental energetics and signalling pathways: Implications for tissue collection
  9. Phosphorylation changes in survival and stress-response signalling pathways in the human placenta as an artefact of delayed tissue collection
  10. Redefining Preeclampsia Using Placenta-Derived Biomarkers
  11. Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis
  12. Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction
  13. Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility
  14. Proceedings of Research in Clinical Practice 2011
  15. A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
  16. Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A–1
  17. Gene network inference and visualization tools for biologists: application to new human transcriptome datasets
  18. Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice
  19. Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?
  20. Functional analysis of the antioxidant paraoxonase-3 in lung epithelial cells by rna interference
  21. Dynamic expression and steroid regulation of sarg, a novel gene in the perinatal lung
  22. Estimating Genome-Wide Gene Networks Using Nonparametric Bayesian Network Models on Massively Parallel Computers
  23. Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis
  24. Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner
  25. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo
  26. MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms
  27. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling
  28. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  29. VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes
  30. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
  31. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  32. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  33. Paraoxonase-3, a Putative Circulating Antioxidant, Is Systemically Up-Regulated in Late Gestation in the Fetal Rat, Sheep, and Human
  34. VEGF-A and Serum Withdrawal Induced Changes in the Transcript Profile in Human Endometrial Endothelial Cells
  35. Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4
  36. The influence of the intrauterine environment on human placental development
  37. Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium
  38. Regulation of vascular growth and function in the human placenta
  39. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys
  40. Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cells
  41. Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia
  42. Characterization of Serotonin Receptors in Pregnant Human Myometrium
  43. Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study
  44. UNRAVELING DYNAMIC ACTIVITIES OF AUTOCRINE PATHWAYS THAT CONTROL DRUG-RESPONSE TRANSCRIPTOME NETWORKS
  45. Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment
  46. Evidence of Placental Translation Inhibition and Endoplasmic Reticulum Stress in the Etiology of Human Intrauterine Growth Restriction
  47. Transcript profile and localization of Wnt signaling–related molecules in human endometrium
  48. The Effect of Delaying Childbirth on Primary Cesarean Section Rates
  49. Stimulation of Contractions in Human Myometrium by Serotonin is Unmasked by Smooth Muscle Relaxants
  50. Statistical inference of transcriptional module-based gene networks from time course gene expression profiles by using state space models
  51. Localization and Control of Expression of VEGF-A and the VEGFR-2 Receptor in Fetal Sheep Intestines
  52. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration
  53. 325: Maternal age and uterine function: A biological basis for rising rates of cesarean delivery
  54. Oxidative Stress, Gene Expression, and Protein Changes Induced in the Human Placenta during Labor
  55. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?
  56. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium
  57. Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment
  58. Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta)
  59. Nuclear Factor-κB, p38, and Stress-Activated Protein Kinase Mitogen-Activated Protein Kinase Signaling Pathways Regulate Proinflammatory Cytokines and Apoptosis in Human Placental Explants in Response to Oxidative Stress
  60. Human Early Placental Development: Potential Roles of the Endometrial Glands
  61. Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization
  62. Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells
  63. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2
  64. Changes in Gene Expression during Wolffian Duct Development
  65. Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT
  66. COMPUTATIONAL STRATEGY FOR DISCOVERING DRUGGABLE GENE NETWORKS FROM GENOME-WIDE RNA EXPRESSION PROFILES
  67. Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception
  68. Vascular growth and modelling in the endometrium
  69. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys
  70. Novel antiangiogenic agents for use in contraception
  71. 126. Progesterone regulates CXCL14 (macrophage inflammatory protein 2γ) mRNA in human endometrium
  72. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma
  73. Independent component analysis of microarray data in the study of endometrial cancer
  74. Secretion of Tumor Necrosis Factor-α from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro
  75. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. I. Molecular Regulation
  76. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. II. Changes During Normal Pregnancy
  77. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. III. Changes in Complicated Pregnancies
  78. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF
  79. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  80. Antiangiogenic Agents Are Effective Inhibitors of Endometriosis
  81. Intralobular Differences in Antioxidant Enzyme Expression and Activity Reflect the Pattern of Maternal Arterial Bloodflow Within the Human Placenta
  82. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor ☆☆This study was supported by grants from the Heart and Stroke Foundation of Ontario (T-3361) and the Canadian Institutes of Health Research (MT-1502...
  83. Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17β-Estradiol in the Mouse Uterus
  84. Identification of Genes with Differential Regulation in Primate Endometrium During the Proliferative and Secretory Phases of the Cycle
  85. Generation and use of a tailored gene array to investigate vascular biology
  86. vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages
  87. Placental Vessel Adaptation During Gestation and to High Altitude: Changes in Diameter and Perivascular Cell Coverage
  88. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle
  89. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function
  90. Is estradiol cardioprotection a nitric oxide-mediated effect?
  91. A longitudinal study of biochemical variables in women at risk of preeclampsia
  92. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature*
  93. Soluble flt and the angiopoietins in the development and regulation of placental vasculature
  94. Large scale analysis of transcripts in human endometrium
  95. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  96. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  97. Angiogenesis and Blood Flow: Implications for Pathobiology—A Workshop Report
  98. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1
  99. Placental Vascular Morphogenesis: Introduction and Overview
  100. Placental vascular morphogenesis
  101. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
  102. Angiogenic growth factor expression in placenta
  103. Angiogenesis in reproduction
  104. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia1
  105. Alternative Splicing of Vascular Endothelial Growth Factor (VEGF)-R1 (FLT-1) pre-mRNA Is Important for the Regulation of VEGF Activity
  106. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies
  107. Expression and Localization of the Th2-type Cytokine Interleukin-13 and Its Receptor in the Placenta During Human Pregnancy
  108. The role of leukaemia inhibitory factor and interleukin-6 in human reproduction
  109. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies
  110. VEGF mRNA Levels in Placentae From Pregnancies Complicated by Pre-Eclampsia
  111. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis
  112. Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production
  113. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
  114. In-vivo gene transfer to the uterine endometrium
  115. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis
  116. PGE2 and TXA2 Production by Isolated Macrophages from Human Placenta
  117. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  118. Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy
  119. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia
  120. Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour
  121. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum
  122. Vascular Endothelial Growth Factor (VEGF) Concentrations Are Elevated in Peritoneal Fluid of Women With Endometriosis
  123. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
  124. Expression of interleukin-13 by first trimester human villous trophoblast
  125. Hepatocyte growth factor and its receptor c-met: Localization and expression in the human placenta
  126. Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy
  127. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
  128. Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha)
  129. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
  130. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
  131. Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  132. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
  133. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
  134. Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction
  135. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
  136. Capture PCR: An Efficient Method for Walking Along Chromosomal DNA and cDNA
  137. Expression of mRNA for vascular endothelial growth factor in human placenta
  138. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
  139. Endothelin-2 mRNA Splice Variants Detected by RT-PCP in Cultured Human Vascular Smooth Muscle and Endothelial Cells
  140. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.
  141. New protocols for DNA sequencing with dye terminators
  142. Linear Amplification Sequencing with Dye Terminators
  143. Working with Oxygen and Oxidative Stress In Vitro
  144. Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction